These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 11442316

  • 1. Inducible nitric oxide synthase knockout mice exhibit resistance to the multiple organ failure induced by zymosan.
    Cuzzocrea S, Mazzon E, Dugo L, Barbera A, Centorrino T, Ciccolo A, Fonti MT, Caputi AP.
    Shock; 2001 Jul; 16(1):51-8. PubMed ID: 11442316
    [Abstract] [Full Text] [Related]

  • 2. Role of interleukin-6 in a non-septic shock model induced by zymosan.
    Cuzzocrea S, de Sarro G, Costantino G, Mazzon E, Laurà R, Ciriaco E, de Sarro A, Caputi AP.
    Eur Cytokine Netw; 1999 Jun; 10(2):191-203. PubMed ID: 10400825
    [Abstract] [Full Text] [Related]

  • 3. Inducible nitric oxide synthase-knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan.
    Cuzzocrea S, Mazzon E, Calabro G, Dugo L, De Sarro A, van De LOO FA, Caputi AP.
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1859-66. PubMed ID: 11069827
    [Abstract] [Full Text] [Related]

  • 4. Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ failure after zymosan-induced peritonitis in the rat.
    Cuzzocrea S, Zingarelli B, Costantino G, Sottile A, Teti D, Caputi AP.
    Crit Care Med; 1999 Aug; 27(8):1517-23. PubMed ID: 10470759
    [Abstract] [Full Text] [Related]

  • 5. Peroxynitrate-mediated DNA strand breakage activates poly(ADP-ribose) synthetase and causes cellular energy depletion in a nonseptic shock model induced by zymosan in the rat.
    Cuzzocrea S, Zingarelli B, Caputi AP.
    Shock; 1998 May; 9(5):336-40. PubMed ID: 9617882
    [Abstract] [Full Text] [Related]

  • 6. Oxidation, tyrosine nitration and cytostasis induction in the absence of inducible nitric oxide synthase.
    Zingarelli B, Virág L, Szabó A, Cuzzocrea S, Salzman AL, Szabó C.
    Int J Mol Med; 1998 May; 1(5):787-95. PubMed ID: 9852297
    [Abstract] [Full Text] [Related]

  • 7. Olprinone, a specific phosphodiesterase (PDE)-III inhibitor, reduces the development of multiple organ dysfunction syndrome in mice.
    Mazzon E, Esposito E, Di Paola R, Impellizzeri D, Bramanti P, Cuzzocrea S.
    Pharmacol Res; 2011 Jul; 64(1):68-79. PubMed ID: 21193041
    [Abstract] [Full Text] [Related]

  • 8. Protective effect of N-acetylcysteine on multiple organ failure induced by zymosan in the rat.
    Cuzzocrea S, Costantino G, Mazzon E, Caputi AP.
    Crit Care Med; 1999 Aug; 27(8):1524-32. PubMed ID: 10470760
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of free radicals and poly(ADP-ribose) synthetase in intestinal tight junction permeability.
    Cuzzocrea S, Mazzon E, De Sarro A, Caputi AP.
    Mol Med; 2000 Sep; 6(9):766-78. PubMed ID: 11071271
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. PD98059, a specific MAP kinase inhibitor, attenuates multiple organ dysfunction syndrome/failure (MODS) induced by zymosan in mice.
    Di Paola R, Galuppo M, Mazzon E, Paterniti I, Bramanti P, Cuzzocrea S.
    Pharmacol Res; 2010 Feb; 61(2):175-87. PubMed ID: 19819333
    [Abstract] [Full Text] [Related]

  • 13. Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice.
    Cuzzocrea S, Rossi A, Pisano B, Di Paola R, Genovese T, Patel NS, Cuzzocrea E, Ianaro A, Sautebin L, Fulia F, Chatterjee PK, Caputi AP, Thiemermann C.
    Intensive Care Med; 2003 Nov; 29(11):2016-25. PubMed ID: 12879239
    [Abstract] [Full Text] [Related]

  • 14. Effects of calpain inhibitor I on multiple organ failure induced by zymosan in the rat.
    Cuzzocrea S, Chatterjee PK, Mazzon E, Serraino I, Dugo L, Centorrino T, Barbera A, Ciccolo A, Fulia F, McDonald MC, Caputi AP, Thiemermann C.
    Crit Care Med; 2002 Oct; 30(10):2284-94. PubMed ID: 12394957
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.